PB Bolton, P Lefevre and DM McDonald
Department of Anatomy, University of California, San Francisco 94143- 0130, USA.

We examined the effect of salmeterol, a long-acting beta2-adrenergic receptor agonist, on ovalbumin-induced plasma leakage and leukocyte adhesion in tracheal blood vessels of unanesthetized brown Norway rats. Ovalbumin challenge of sensitized rats resulted in both early and late phases of plasma leakage as measured with Evans blue. The early phase occurred during the challenge. The late phase began 2 h after the challenge, peaked at 4 h, and ended by 24 h. Ovalbumin challenge also increased the number of adherent leukocytes in mucosal blood vessels at 4 h. Nebulized salmeterol (5 mg/ml for 10 min) administered before the challenge inhibited the early-phase leak by 26%, 58%, or 85%, depending upon whether the interval between pretreatment and challenge was 0.5, 1, or 4.5 h, respectively. Similarly, salmeterol pretreatment (0.05 to 5 mg/ml for 10 min) reduced the late-phase leak at 4 h. Late-phase leakage was completely blocked at concentrations of 0.5 mg/ml or greater. This inhibitory effect was prevented by prior injection of the beta2-adrenergic receptor antagonist ICI-118,551. Salmeterol pretreatment also reduced the adherence of neutrophils, eosinophils, monocytes, and lymphocytes in mucosal blood vessels at 4 h. We conclude that salmeterol pretreatment can reduce the plasma leakage and leukocyte adhesion in early- and late-phase responses after antigen challenge through its action on beta2 receptors.

This article has been cited by other articles:

				J G Koopmans, R Lutter, H M Jansen, and J S van der Zee Adding salmeterol to an inhaled corticosteroid: long term effects on bronchial inflammation in asthma Thorax, April 1, 2006; 61(4): 306 - 313. [Abstract] [Full Text] [PDF]

				N. A. Maris, A. F. de Vos, M. C. Dessing, C. A. Spek, R. Lutter, H. M. Jansen, J. S. van der Zee, P. Bresser, and T. van der Poll Antiinflammatory Effects of Salmeterol after Inhalation of Lipopolysaccharide by Healthy Volunteers Am. J. Respir. Crit. Care Med., October 1, 2005; 172(7): 878 - 884. [Abstract] [Full Text] [PDF]

				S. E. Overbeek, P. G. Mulder, S. M. Baelemans, H. C. Hoogsteden, and J.-B. Prins Formoterol Added to Low-Dose Budesonide Has No Additional Antiinflammatory Effect in Asthmatic Patients Chest, September 1, 2005; 128(3): 1121 - 1127. [Abstract] [Full Text] [PDF]

				P. J. Barnes and R. A. Stockley COPD: current therapeutic interventions and future approaches Eur. Respir. J., June 1, 2005; 25(6): 1084 - 1106. [Abstract] [Full Text] [PDF]

				P. J. Barnes Distribution of Receptor Targets in the Lung Proceedings of the ATS, December 1, 2004; 1(4): 345 - 351. [Abstract] [Full Text] [PDF]

				S. Myo, X. Zhu, S. Myou, A.Y. Meliton, J. Liu, E. Boetticher, A.T. Lambertino, C. Xu, N.M. Munoz, and A.R. Leff Additive blockade of {beta}2-integrin adhesion of eosinophils by salmeterol and fluticasone propionate Eur. Respir. J., April 1, 2004; 23(4): 511 - 517. [Abstract] [Full Text] [PDF]

				J. Gabrijelcic, A. Casas, R.A. Rabinovich, J. Roca, J.A. Barbera, K.F. Chung, and R. Rodriguez-Roisin Formoterol protects against platelet-activating factor-induced effects in asthma Eur. Respir. J., January 1, 2004; 23(1): 71 - 75. [Abstract] [Full Text] [PDF]

				J. S. Erjefalt, M. Korsgren, M. Malm-Erjefalt, D. M. Conroy, T. J. Williams, and C. G. A. Persson Acute Allergic Responses Induce a Prompt Luminal Entry of Airway Tissue Eosinophils Am. J. Respir. Cell Mol. Biol., October 1, 2003; 29(4): 439 - 448. [Abstract] [Full Text] [PDF]

				I. Tillie-Leblond, B. P. H. Guery, A. Janin, R. Leberre, N. Just, J.-F. Pittet, A.-B. Tonnel, and P. Gosset Chronic bronchial allergic inflammation increases alveolar liquid clearance by TNF-alpha -dependent mechanism Am J Physiol Lung Cell Mol Physiol, December 1, 2002; 283(6): L1303 - L1309. [Abstract] [Full Text] [PDF]

				N. J. Vanacker, E. Palmans, R. A. Pauwels, and J. C. Kips Effect of Combining Salmeterol and Fluticasone on the Progression of Airway Remodeling Am. J. Respir. Crit. Care Med., October 15, 2002; 166(8): 1128 - 1134. [Abstract] [Full Text] [PDF]

				A. M. Joussen, V. Poulaki, A. Tsujikawa, W. Qin, T. Qaum, Q. Xu, Y. Moromizato, S.-E. Bursell, S. J. Wiegand, J. Rudge, et al. Suppression of Diabetic Retinopathy with Angiopoietin-1 Am. J. Pathol., May 1, 2002; 160(5): 1683 - 1693. [Abstract] [Full Text] [PDF]

				P.J. Barnes Scientific rationale for inhaled combination therapy with long-acting {beta}2-agonists and corticosteroids Eur. Respir. J., January 1, 2002; 19(1): 182 - 191. [Abstract] [Full Text] [PDF]

				D. M. MCDONALD Angiogenesis and Remodeling of Airway Vasculature in Chronic Inflammation Am. J. Respir. Crit. Care Med., November 15, 2001; 164(10): S39 - 45. [Abstract] [Full Text] [PDF]

				A. M. Joussen, W.-D. Beecken, Y. Moromizato, A. Schwartz, B. Kirchhof, and V. Poulaki Inhibition of Inflammatory Corneal Angiogenesis by TNP-470 Invest. Ophthalmol. Vis. Sci., October 1, 2001; 42(11): 2510 - 2516. [Abstract] [Full Text] [PDF]

				M. Johnson and S. Rennard Alternative Mechanisms for Long-Acting {beta}2-Adrenergic Agonists in COPD Chest, July 1, 2001; 120(1): 258 - 270. [Abstract] [Full Text] [PDF]

				Q. Xu, T. Qaum, and A. P. Adamis Sensitive Blood-Retinal Barrier Breakdown Quantitation Using Evans Blue Invest. Ophthalmol. Vis. Sci., March 1, 2001; 42(3): 789 - 794. [Abstract] [Full Text]

				M. L. Kwan, A. D. Gomez, P. Baluk, H. Hashizume, and D. M. McDonald Airway vasculature after mycoplasma infection: chronic leakiness and selective hypersensitivity to substance P Am J Physiol Lung Cell Mol Physiol, February 1, 2001; 280(2): L286 - L297. [Abstract] [Full Text] [PDF]

				X. LI, C. WARD, F. THIEN, R. BISH, T. BAMFORD, X. BAO, M. BAILEY, J. W. WILSON, and E. HAYDN WALTERS An Antiinflammatory Effect of Salmeterol, a Long-acting beta 2 Agonist, Assessed in Airway Biopsies and Bronchoalveolar Lavage in Asthma Am. J. Respir. Crit. Care Med., November 1, 1999; 160(5): 1493 - 1499. [Abstract] [Full Text]

				R. S. Peebles Jr., S. Permutt, and A. Togias Rapid reversibility of the allergen-induced pulmonary late-phase reaction by an intravenous beta 2-agonist J Appl Physiol, May 1, 1998; 84(5): 1500 - 1505. [Abstract] [Full Text] [PDF]